AU2002248646A1 - Compositions and methods for modulating an immune response - Google Patents

Compositions and methods for modulating an immune response

Info

Publication number
AU2002248646A1
AU2002248646A1 AU2002248646A AU2002248646A AU2002248646A1 AU 2002248646 A1 AU2002248646 A1 AU 2002248646A1 AU 2002248646 A AU2002248646 A AU 2002248646A AU 2002248646 A AU2002248646 A AU 2002248646A AU 2002248646 A1 AU2002248646 A1 AU 2002248646A1
Authority
AU
Australia
Prior art keywords
modulating
compositions
methods
immune response
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002248646A
Other languages
English (en)
Inventor
David H. Broide
Eyal Raz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2002248646A1 publication Critical patent/AU2002248646A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002248646A 2001-03-16 2002-03-15 Compositions and methods for modulating an immune response Abandoned AU2002248646A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27686501P 2001-03-16 2001-03-16
US60/276,865 2001-03-16
PCT/US2002/008207 WO2002074922A2 (fr) 2001-03-16 2002-03-15 Compositions et procedes permettant de moduler une reponse immunitaire

Publications (1)

Publication Number Publication Date
AU2002248646A1 true AU2002248646A1 (en) 2002-10-03

Family

ID=23058390

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002248646A Abandoned AU2002248646A1 (en) 2001-03-16 2002-03-15 Compositions and methods for modulating an immune response

Country Status (2)

Country Link
AU (1) AU2002248646A1 (fr)
WO (1) WO2002074922A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1077722T1 (sl) 1998-05-22 2007-02-28 Ottawa Health Research Inst Metode in produkti za induciranje sluznicne imunosti
AU2002345847B2 (en) 2001-06-21 2008-05-29 Dynavax Technologies Corporation Chimeric immunomodulatory compounds and methods of using the same
SI1575977T1 (sl) 2002-12-23 2010-01-29 Dynavax Tech Corp Imunostimulirni sekvenčni polinukleotidi in postopki za njihovo uporabo
US8158768B2 (en) 2002-12-23 2012-04-17 Dynavax Technologies Corporation Immunostimulatory sequence oligonucleotides and methods of using the same

Also Published As

Publication number Publication date
WO2002074922A2 (fr) 2002-09-26
WO2002074922A3 (fr) 2003-02-20

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AUPR956901A0 (en) Real time translator
AU2002315407A1 (en) Compositions and methods for modulating plant development
AU2008243079A1 (en) Compositions and methods for generating an immune response
AU2002242085A1 (en) Methods and compositions useful for stimulating an immune response
AUPR510001A0 (en) Formulation and method
AU2002361623A1 (en) Methods and compositions for chromatography
IL145891A0 (en) Methods and compositions for modulating an immune response
AU7968398A (en) Compositions, devices, kit and method for modulating immune response
AU2002309486A1 (en) Methods and compositions for modulating the immune system of animals
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU7474100A (en) Methods and compositions for reducing immune response
AU2002242175A1 (en) Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a
AU2002332598A1 (en) Compositions and methods for generating antigen-binding units
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2001253481A1 (en) Methods and compositions for eleciting an immune response
AU2003225710A1 (en) Composition and method for enhancing immune response
AUPR446801A0 (en) Novel compositions and uses therefor
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AU2002248646A1 (en) Compositions and methods for modulating an immune response
AU2002352153A1 (en) Instant emulsion
AU2002338571A1 (en) Compositions and methods for suppressing immune responses
AU2002332507A1 (en) Levothyroxine compositions and methods
AU2002365136A1 (en) Compositions and methods for controlled release
AU2002329406A1 (en) An osteoprosthesis component

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase